Nancy A Neilan

Summary

Affiliation: Children's Mercy Hospital
Country: USA

Publications

  1. pmc Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
    Craig A Friesen
    Department of Pediatrics, The Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, Missouri, USA
    BMC Res Notes 4:322. 2011
  2. doi request reprint Useful biomarkers in pediatric eosinophilic duodenitis and their existence: a case-control, single-blind, observational pilot study
    Nancy A Neilan
    Section of Gastroenterology, Children s Mercy Hospital, Kansas City, MO 64108, USA
    J Pediatr Gastroenterol Nutr 50:377-84. 2010
  3. pmc Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics
    Craig A Friesen
    The Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
    BMC Gastroenterol 9:32. 2009

Collaborators

Detail Information

Publications3

  1. pmc Mast cell activation and clinical outcome in pediatric cholelithiasis and biliary dyskinesia
    Craig A Friesen
    Department of Pediatrics, The Children s Mercy Hospital, 2401 Gillham Rd, Kansas City, Missouri, USA
    BMC Res Notes 4:322. 2011
    ..abstract:..
  2. doi request reprint Useful biomarkers in pediatric eosinophilic duodenitis and their existence: a case-control, single-blind, observational pilot study
    Nancy A Neilan
    Section of Gastroenterology, Children s Mercy Hospital, Kansas City, MO 64108, USA
    J Pediatr Gastroenterol Nutr 50:377-84. 2010
    ..The aim of this study was to determine whether screening for food hypersensitivity could be a clinically useful biomarker for eosinophilic duodenitis in the pediatric population...
  3. pmc Montelukast in the treatment of duodenal eosinophilia in children with dyspepsia: effect on eosinophil density and activation in relation to pharmacokinetics
    Craig A Friesen
    The Children s Mercy Hospital and Clinics, Kansas City, Missouri, USA
    BMC Gastroenterol 9:32. 2009
    ..The mechanism of this clinical response is unknown but could involve a decrease in eosinophil density or activation...